טוען...
Proof of concept demonstration of optimal composite MRI endpoints for clinical trials
INTRODUCTION: Atrophy measures derived from structural MRI are promising outcome measures for early phase clinical trials, especially for rare diseases such as primary progressive aphasia (PPA), where the small available subject pool limits our ability to perform meaningfully powered trials with tra...
שמור ב:
| הוצא לאור ב: | Alzheimers Dement (N Y) |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5363955/ https://ncbi.nlm.nih.gov/pubmed/28345017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2016.05.002 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|